Fm. Dautzenberg et al., Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: Evidence for evolutionary differences, J PHARM EXP, 296(1), 2001, pp. 113-120
Citations number
31
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
The binding characteristics of corticotropin-releasing factor (CRF) type 1
(CRF1) and type 2 (CRF2) receptors from human (hCRF(1) and hCRF(2 alpha)) a
nd Xenopus (xCRF(1) and xCRF(2)) were compared using four different I-125-l
abeled CRF analogs, the agonists I-125-CRF and I-125-sauvagine, and the ant
agonists I-125-astressin (I-125-AST) and I-125-antisauvagine-30 (I-125-aSVG
). The hCRF(2 alpha) and xCRF(2) receptors bound all four radioligands with
different affinities, whereas hCRF(1) did not bind I-125-aSVG, and xCRF(1)
bound neither I-125-sauvagine nor I-125-aSVG. Competitive binding studies
using unlabeled agonists and antagonists with hCRF(1) and hCRF(2 alpha) rec
eptors revealed that most agonists exhibited higher affinity in displacing
agonist radioligands compared with displacement of antagonist radioligands.
Exceptions were the agonists human and rat urocortin, which displayed high
-affinity binding in the presence of either I-125-labeled agonist or antago
nist ligands. In contrast, the affinities of antagonists were independent o
f the nature of the radioligand. We also found that, in contrast to the mam
malian CRF receptors, the affinity of ligand binding to xCRF(1) and xCRF(2)
receptors strongly depended on the nature of the radioligand used for comp
etition. For xCRF(1), competitors showed different rank order binding profi
les with I-125-CRF compared with I-125-AST as the displaceable ligand. Simi
larly, binding of competitors to the xCRF(2) receptor showed markedly diffe
rent profiles with I-125-CRF as the competed ligand compared with the other
radioligands. These data demonstrate that amphibian CRF receptors have dis
tinctly different binding modes compared with their mammalian counterparts.